ÂÜÀòÂÒÂ×

Christina Kurre Olsen, PhD has more than 20 years of research expertise in neuroscience, neuropsychopharmacology, CNS therapeutics and monoclonal antibody immunotherapy spanning broadly as a research scientist in drug discovery and currently as medical director in clinical development.

Dr Kurre Olsen has strong hands-on knowledge across the value chain from discovery, development and approval of innovative medicines with a passion for cognition. As a clinical lead, Dr Kurre Olsen had an instrumental role in driving and implementing the strategy for moving a late-stage program towards targeting cognitive dysfunction in depression. She recently moved to biotech within clinical research of lysosomal storage diseases and expanding her expertise to rare disorders.

Dr Kurre Olsen has in depth insights in regulatory interactions and a special interest in multidisciplinary strategies enabling innovative research with the end goal of regulatory approval and market access.